Category Lead, Oncology, Primary Care, Rare Disease & Internal Medicine - North Africa

The Category Lead, Oncology, Primary Care, Rare Disease & Internal Medicine - North Africa is a strategic member of the North Africa Leadership Team, accountable for the end-to-end strategy, performance and long-term value of the assigned portfolio across Morocco, Algeria, Tunisia and Libya.

The role translates enterprise and regional priorities into differentiated portfolio and market strategies that balance near-term delivery with sustainable growth and patient impact. It brings together categories with distinctly different business models, from large-scale Primary Care and Internal Medicine portfolios to the specialized clinical pathways, diagnostics, access requirements and patient journeys of Oncology and Rare Disease.

The Category Lead sets clear priorities across therapeutic areas, brands, markets, launches, customer segments and investments, ensuring resources are deployed where they can generate the greatest sustainable value for patients and the business.

Core Accountabilities:

1. Category Strategy & Multi-Portfolio Leadership

• Own and translate the North Africa strategy for Oncology, Primary Care, Rare Disease and Internal Medicine into clear portfolio, brand, market and customer priorities.
• Lead end-to-end portfolio planning across established brands, Growth Knots, new indications, pipeline assets and future launches.
• Develop differentiated strategies reflecting the specific dynamics of Morocco, Algeria, Tunisia and Libya, including market maturity, patient needs, clinical pathways, access conditions, competitive environment and healthcare-system priorities.

1. Business & P&L Leadership

• Own overall category business performance, with accountability for revenue, market share, profitability, investment priorities and effective resource deployment.
• Lead annual operating planning and long-range planning across the portfolio and four markets, supported by robust assumptions, scenarios, forecasts and risk assessments.

1. Portfolio Growth & Lifecycle Management

• Develop differentiated growth strategies across therapeutic areas and stages of the product lifecycle.
• Accelerate priority growth platforms and maximize the value of relevant in-line brands and new indications.

1. New Launches & Pipeline Readiness

• Lead integrated launch strategy and readiness for new assets, indications and presentations across North Africa.
• Define launch ambition, market sequencing, investment requirements, customer strategy and critical success factors.

1. Patient Journey, Diagnostics & Healthcare Ecosystem Development

• Develop a deep understanding of patient journeys across Oncology, Rare Disease, Primary Care and Internal Medicine.
• Identify barriers across disease awareness, diagnosis, referral, treatment initiation, monitoring, adherence and continuity of care.

1. Market Shaping & Patient Access

• Partner with Access & Value, Medical, Policy & Public Affairs and Regulatory to develop the enabling environment for sustainable patient access.
• Embed reimbursement, affordability, payer, policy and market-shaping considerations into portfolio and launch plans.

1. Go-To-Market & Customer Leadership

• Translate portfolio strategy into differentiated customer and go-to-market strategies appropriate to each therapeutic area and market.
• Partner with market and Sales leadership to convert category strategy into executable local plans with clear ownership and success measures.

1. Cross-Functional & Four-Market Leadership

• Lead category teams across Morocco, Algeria, Tunisia and Libya, establishing clear accountability between cluster strategy and local execution.
• Create an operating model that preserves one North Africa portfolio direction while allowing deliberate market differentiation.

1. Organization & People Leadership

• Build a high-performing and inclusive North Africa category organization capable of managing a diverse portfolio.
• Establish clear roles and decision rights between cluster-level category leadership and market/customer-facing execution.

Decision Rights:

• Set strategic direction and portfolio priorities for Oncology, Rare Disease and Internal Medicine across North Africa within approved enterprise, regional and cluster governance.
• Recommend operating-plan assumptions and determine the allocation of approved category marketing investments across brands, therapeutic areas and markets.

Capabilities & Qualifications:

• Bachelor's degree in Life Sciences, Pharmacy, Medicine, Business or a related field; an MBA or equivalent advanced degree is preferred.
• At least 10 years of pharmaceutical or healthcare experience, including significant commercial leadership responsibility.
• Demonstrated success leading complex pharmaceutical portfolios, launches and cross-functional business priorities.